Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues

Angiogenic factors (AF) promote vascular formation and may thus support neuroendocrine tumour (NET) development. This study aimed to assess AF serum level changes in NET patients treated with prolonged-acting somatostatin analogues (SSAs). The study enrolled 49 healthy volunteers (Group A) and 56 NE...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosiek, Violetta, Janas, Ksenia, Kos-Kudła, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044914/
https://www.ncbi.nlm.nih.gov/pubmed/36979820
http://dx.doi.org/10.3390/biomedicines11030842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044914/
https://www.ncbi.nlm.nih.gov/pubmed/36979820
http://dx.doi.org/10.3390/biomedicines11030842

Ejemplares similares